Medical Care
Global Breast Cancer Predictive Genetic Testing Market Research Report 2024
- Mar 12, 24
- ID: 114519
- Pages: 80
- Figures: 158
- Views: 24
The global Breast Cancer Predictive Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Predictive Genetic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Predictive Genetic Testing include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Predictive Genetic Testing.
Report Scope
The Breast Cancer Predictive Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Predictive Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Predictive Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Segment by Type
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Predictive Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Breast Cancer Predictive Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Breast Cancer Predictive Genetic Testing in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Breast Cancer Predictive Genetic Testing include Roche, Thermo Fisher Scientific, PerkinElmer, Quest Diagnostics, Myriad Genetics, Iverson Genetics, Cancer Genetics, OncoCyte Corporation and NeoGenomics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Breast Cancer Predictive Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Predictive Genetic Testing.
Report Scope
The Breast Cancer Predictive Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Breast Cancer Predictive Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Breast Cancer Predictive Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
PerkinElmer
Quest Diagnostics
Myriad Genetics
Iverson Genetics
Cancer Genetics
OncoCyte Corporation
NeoGenomics
Invitae
Segment by Type
High Penetrant Genes
Intermediate Penetrant Genes
Low Penetrant Genes
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Predictive Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 High Penetrant Genes
1.2.3 Intermediate Penetrant Genes
1.2.4 Low Penetrant Genes
1.3 Market by Application
1.3.1 Global Breast Cancer Predictive Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2019-2030)
2.2 Breast Cancer Predictive Genetic Testing Growth Trends by Region
2.2.1 Global Breast Cancer Predictive Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Predictive Genetic Testing Market Dynamics
2.3.1 Breast Cancer Predictive Genetic Testing Industry Trends
2.3.2 Breast Cancer Predictive Genetic Testing Market Drivers
2.3.3 Breast Cancer Predictive Genetic Testing Market Challenges
2.3.4 Breast Cancer Predictive Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue
3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue
3.4 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2023
3.5 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served
3.6 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
3.7 Date of Enter into Breast Cancer Predictive Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Predictive Genetic Testing Breakdown Data by Type
4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Predictive Genetic Testing Breakdown Data by Application
5.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
6.2 North America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
7.2 Europe Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
9.2 Latin America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction
11.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction
11.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction
11.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.5.5 Myriad Genetics Recent Development
11.6 Iverson Genetics
11.6.1 Iverson Genetics Company Detail
11.6.2 Iverson Genetics Business Overview
11.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction
11.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.6.5 Iverson Genetics Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Detail
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction
11.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.7.5 Cancer Genetics Recent Development
11.8 OncoCyte Corporation
11.8.1 OncoCyte Corporation Company Detail
11.8.2 OncoCyte Corporation Business Overview
11.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction
11.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.8.5 OncoCyte Corporation Recent Development
11.9 NeoGenomics
11.9.1 NeoGenomics Company Detail
11.9.2 NeoGenomics Business Overview
11.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction
11.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.9.5 NeoGenomics Recent Development
11.10 Invitae
11.10.1 Invitae Company Detail
11.10.2 Invitae Business Overview
11.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction
11.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.10.5 Invitae Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 High Penetrant Genes
1.2.3 Intermediate Penetrant Genes
1.2.4 Low Penetrant Genes
1.3 Market by Application
1.3.1 Global Breast Cancer Predictive Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Predictive Genetic Testing Market Perspective (2019-2030)
2.2 Breast Cancer Predictive Genetic Testing Growth Trends by Region
2.2.1 Global Breast Cancer Predictive Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Breast Cancer Predictive Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Breast Cancer Predictive Genetic Testing Market Dynamics
2.3.1 Breast Cancer Predictive Genetic Testing Industry Trends
2.3.2 Breast Cancer Predictive Genetic Testing Market Drivers
2.3.3 Breast Cancer Predictive Genetic Testing Market Challenges
2.3.4 Breast Cancer Predictive Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue
3.1.1 Global Top Breast Cancer Predictive Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Predictive Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Predictive Genetic Testing Revenue
3.4 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio
3.4.1 Global Breast Cancer Predictive Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Predictive Genetic Testing Revenue in 2023
3.5 Breast Cancer Predictive Genetic Testing Key Players Head office and Area Served
3.6 Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
3.7 Date of Enter into Breast Cancer Predictive Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Predictive Genetic Testing Breakdown Data by Type
4.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Breast Cancer Predictive Genetic Testing Breakdown Data by Application
5.1 Global Breast Cancer Predictive Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
6.2 North America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
6.4 North America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
7.2 Europe Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
9.2 Latin America Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Breast Cancer Predictive Genetic Testing Introduction
11.1.4 Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Breast Cancer Predictive Genetic Testing Introduction
11.3.4 PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Introduction
11.4.4 Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.4.5 Quest Diagnostics Recent Development
11.5 Myriad Genetics
11.5.1 Myriad Genetics Company Detail
11.5.2 Myriad Genetics Business Overview
11.5.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Introduction
11.5.4 Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.5.5 Myriad Genetics Recent Development
11.6 Iverson Genetics
11.6.1 Iverson Genetics Company Detail
11.6.2 Iverson Genetics Business Overview
11.6.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Introduction
11.6.4 Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.6.5 Iverson Genetics Recent Development
11.7 Cancer Genetics
11.7.1 Cancer Genetics Company Detail
11.7.2 Cancer Genetics Business Overview
11.7.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Introduction
11.7.4 Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.7.5 Cancer Genetics Recent Development
11.8 OncoCyte Corporation
11.8.1 OncoCyte Corporation Company Detail
11.8.2 OncoCyte Corporation Business Overview
11.8.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Introduction
11.8.4 OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.8.5 OncoCyte Corporation Recent Development
11.9 NeoGenomics
11.9.1 NeoGenomics Company Detail
11.9.2 NeoGenomics Business Overview
11.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Introduction
11.9.4 NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.9.5 NeoGenomics Recent Development
11.10 Invitae
11.10.1 Invitae Company Detail
11.10.2 Invitae Business Overview
11.10.3 Invitae Breast Cancer Predictive Genetic Testing Introduction
11.10.4 Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024)
11.10.5 Invitae Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of High Penetrant Genes
Table 3. Key Players of Intermediate Penetrant Genes
Table 4. Key Players of Low Penetrant Genes
Table 5. Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Breast Cancer Predictive Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2019-2024)
Table 9. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2025-2030)
Table 11. Breast Cancer Predictive Genetic Testing Market Trends
Table 12. Breast Cancer Predictive Genetic Testing Market Drivers
Table 13. Breast Cancer Predictive Genetic Testing Market Challenges
Table 14. Breast Cancer Predictive Genetic Testing Market Restraints
Table 15. Global Breast Cancer Predictive Genetic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Breast Cancer Predictive Genetic Testing Market Share by Players (2019-2024)
Table 17. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2023)
Table 18. Ranking of Global Top Breast Cancer Predictive Genetic Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Breast Cancer Predictive Genetic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
Table 22. Date of Enter into Breast Cancer Predictive Genetic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Predictive Genetic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Breast Cancer Predictive Genetic Testing Product
Table 50. Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product
Table 55. Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. PerkinElmer Company Detail
Table 58. PerkinElmer Business Overview
Table 59. PerkinElmer Breast Cancer Predictive Genetic Testing Product
Table 60. PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 61. PerkinElmer Recent Development
Table 62. Quest Diagnostics Company Detail
Table 63. Quest Diagnostics Business Overview
Table 64. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product
Table 65. Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 66. Quest Diagnostics Recent Development
Table 67. Myriad Genetics Company Detail
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Breast Cancer Predictive Genetic Testing Product
Table 70. Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. Iverson Genetics Company Detail
Table 73. Iverson Genetics Business Overview
Table 74. Iverson Genetics Breast Cancer Predictive Genetic Testing Product
Table 75. Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 76. Iverson Genetics Recent Development
Table 77. Cancer Genetics Company Detail
Table 78. Cancer Genetics Business Overview
Table 79. Cancer Genetics Breast Cancer Predictive Genetic Testing Product
Table 80. Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 81. Cancer Genetics Recent Development
Table 82. OncoCyte Corporation Company Detail
Table 83. OncoCyte Corporation Business Overview
Table 84. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product
Table 85. OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 86. OncoCyte Corporation Recent Development
Table 87. NeoGenomics Company Detail
Table 88. NeoGenomics Business Overview
Table 89. NeoGenomics Breast Cancer Predictive Genetic Testing Product
Table 90. NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 91. NeoGenomics Recent Development
Table 92. Invitae Company Detail
Table 93. Invitae Business Overview
Table 94. Invitae Breast Cancer Predictive Genetic Testing Product
Table 95. Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 96. Invitae Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Breast Cancer Predictive Genetic Testing Market Share by Type: 2023 VS 2030
Figure 3. High Penetrant Genes Features
Figure 4. Intermediate Penetrant Genes Features
Figure 5. Low Penetrant Genes Features
Figure 6. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Predictive Genetic Testing Report Years Considered
Figure 12. Global Breast Cancer Predictive Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Breast Cancer Predictive Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Breast Cancer Predictive Genetic Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Breast Cancer Predictive Genetic Testing Market Share by Players in 2023
Figure 16. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2023
Figure 18. North America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 20. United States Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 24. Germany Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Share by Region (2019-2030)
Figure 32. China Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 40. Mexico Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 44. Turkey Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 48. PerkinElmer Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 49. Quest Diagnostics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 50. Myriad Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 51. Iverson Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 52. Cancer Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 53. OncoCyte Corporation Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 54. NeoGenomics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 55. Invitae Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of High Penetrant Genes
Table 3. Key Players of Intermediate Penetrant Genes
Table 4. Key Players of Low Penetrant Genes
Table 5. Global Breast Cancer Predictive Genetic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Breast Cancer Predictive Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2019-2024)
Table 9. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Breast Cancer Predictive Genetic Testing Market Share by Region (2025-2030)
Table 11. Breast Cancer Predictive Genetic Testing Market Trends
Table 12. Breast Cancer Predictive Genetic Testing Market Drivers
Table 13. Breast Cancer Predictive Genetic Testing Market Challenges
Table 14. Breast Cancer Predictive Genetic Testing Market Restraints
Table 15. Global Breast Cancer Predictive Genetic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Breast Cancer Predictive Genetic Testing Market Share by Players (2019-2024)
Table 17. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2023)
Table 18. Ranking of Global Top Breast Cancer Predictive Genetic Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Breast Cancer Predictive Genetic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Breast Cancer Predictive Genetic Testing Product Solution and Service
Table 22. Date of Enter into Breast Cancer Predictive Genetic Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Breast Cancer Predictive Genetic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Breast Cancer Predictive Genetic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Breast Cancer Predictive Genetic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Breast Cancer Predictive Genetic Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Roche Company Detail
Table 48. Roche Business Overview
Table 49. Roche Breast Cancer Predictive Genetic Testing Product
Table 50. Roche Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 51. Roche Recent Development
Table 52. Thermo Fisher Scientific Company Detail
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product
Table 55. Thermo Fisher Scientific Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. PerkinElmer Company Detail
Table 58. PerkinElmer Business Overview
Table 59. PerkinElmer Breast Cancer Predictive Genetic Testing Product
Table 60. PerkinElmer Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 61. PerkinElmer Recent Development
Table 62. Quest Diagnostics Company Detail
Table 63. Quest Diagnostics Business Overview
Table 64. Quest Diagnostics Breast Cancer Predictive Genetic Testing Product
Table 65. Quest Diagnostics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 66. Quest Diagnostics Recent Development
Table 67. Myriad Genetics Company Detail
Table 68. Myriad Genetics Business Overview
Table 69. Myriad Genetics Breast Cancer Predictive Genetic Testing Product
Table 70. Myriad Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 71. Myriad Genetics Recent Development
Table 72. Iverson Genetics Company Detail
Table 73. Iverson Genetics Business Overview
Table 74. Iverson Genetics Breast Cancer Predictive Genetic Testing Product
Table 75. Iverson Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 76. Iverson Genetics Recent Development
Table 77. Cancer Genetics Company Detail
Table 78. Cancer Genetics Business Overview
Table 79. Cancer Genetics Breast Cancer Predictive Genetic Testing Product
Table 80. Cancer Genetics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 81. Cancer Genetics Recent Development
Table 82. OncoCyte Corporation Company Detail
Table 83. OncoCyte Corporation Business Overview
Table 84. OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product
Table 85. OncoCyte Corporation Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 86. OncoCyte Corporation Recent Development
Table 87. NeoGenomics Company Detail
Table 88. NeoGenomics Business Overview
Table 89. NeoGenomics Breast Cancer Predictive Genetic Testing Product
Table 90. NeoGenomics Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 91. NeoGenomics Recent Development
Table 92. Invitae Company Detail
Table 93. Invitae Business Overview
Table 94. Invitae Breast Cancer Predictive Genetic Testing Product
Table 95. Invitae Revenue in Breast Cancer Predictive Genetic Testing Business (2019-2024) & (US$ Million)
Table 96. Invitae Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Breast Cancer Predictive Genetic Testing Market Share by Type: 2023 VS 2030
Figure 3. High Penetrant Genes Features
Figure 4. Intermediate Penetrant Genes Features
Figure 5. Low Penetrant Genes Features
Figure 6. Global Breast Cancer Predictive Genetic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Breast Cancer Predictive Genetic Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Breast Cancer Predictive Genetic Testing Report Years Considered
Figure 12. Global Breast Cancer Predictive Genetic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Breast Cancer Predictive Genetic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Breast Cancer Predictive Genetic Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Breast Cancer Predictive Genetic Testing Market Share by Players in 2023
Figure 16. Global Top Breast Cancer Predictive Genetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Predictive Genetic Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Predictive Genetic Testing Revenue in 2023
Figure 18. North America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 20. United States Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 24. Germany Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Breast Cancer Predictive Genetic Testing Market Share by Region (2019-2030)
Figure 32. China Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 40. Mexico Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Breast Cancer Predictive Genetic Testing Market Share by Country (2019-2030)
Figure 44. Turkey Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Breast Cancer Predictive Genetic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 48. PerkinElmer Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 49. Quest Diagnostics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 50. Myriad Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 51. Iverson Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 52. Cancer Genetics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 53. OncoCyte Corporation Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 54. NeoGenomics Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 55. Invitae Revenue Growth Rate in Breast Cancer Predictive Genetic Testing Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232